Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Oncology Drugs Market, by Indication
1.4.2 LAMEA Oncology Drugs Market, by Drug Class Type
1.4.3 LAMEA Oncology Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2019, Mar – 2023, Nov) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. LAMEA Oncology Drugs Market by Indication
5.1 LAMEA Breast Cancer Market by Country
5.2 LAMEA Prostate Cancer Market by Country
5.3 LAMEA Lung Cancer Market by Country
5.4 LAMEA Stomach Cancer Market by Country
5.5 LAMEA Colorectal Cancer Market by Country
5.6 LAMEA Liver Cancer Market by Country
5.7 LAMEA Esophagus Cancer Market by Country
5.8 LAMEA Cervical Cancer Market by Country
5.9 LAMEA Kidney Cancer Market by Country
5.10. LAMEA Bladder Cancer Market by Country
5.11 LAMEA Other Cancer Market by Country
Chapter 6. LAMEA Oncology Drugs Market by Drug Class Type
6.1 LAMEA Targeted Therapy Market by Country
6.2 LAMEA Immunotherapy (Biologic Therapy) Market by Country
6.3 LAMEA Chemotherapy Market by Country
6.4 LAMEA Hormonal Therapy Market by Country
Chapter 7. LAMEA Oncology Drugs Market by Country
7.1 Brazil Oncology Drugs Market
7.1.1 Brazil Oncology Drugs Market by Indication
7.1.2 Brazil Oncology Drugs Market by Drug Class Type
7.2 Argentina Oncology Drugs Market
7.2.1 Argentina Oncology Drugs Market by Indication
7.2.2 Argentina Oncology Drugs Market by Drug Class Type
7.3 UAE Oncology Drugs Market
7.3.1 UAE Oncology Drugs Market by Indication
7.3.2 UAE Oncology Drugs Market by Drug Class Type
7.4 Saudi Arabia Oncology Drugs Market
7.4.1 Saudi Arabia Oncology Drugs Market by Indication
7.4.2 Saudi Arabia Oncology Drugs Market by Drug Class Type
7.5 South Africa Oncology Drugs Market
7.5.1 South Africa Oncology Drugs Market by Indication
7.5.2 South Africa Oncology Drugs Market by Drug Class Type
7.6 Nigeria Oncology Drugs Market
7.6.1 Nigeria Oncology Drugs Market by Indication
7.6.2 Nigeria Oncology Drugs Market by Drug Class Type
7.7 Rest of LAMEA Oncology Drugs Market
7.7.1 Rest of LAMEA Oncology Drugs Market by Indication
7.7.2 Rest of LAMEA Oncology Drugs Market by Drug Class Type
Chapter 8. Company Profiles
8.1 AbbVie, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Amgen, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Astellas Pharma, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 AstraZeneca PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.6 SWOT Analysis
8.5 Bristol Myers Squibb Company
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Acquisition and Mergers:
8.5.6 SWOT Analysis
8.6 F. Hoffmann-La Roche Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Johnson & Johnson
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental & Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.7.6 SWOT Analysis
8.8 Novartis AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.6 SWOT Analysis
8.9 Merck & Co., Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.5.2 Acquisition and Mergers:
8.9.6 SWOT Analysis
8.10. Pfizer, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional & Segmental Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.6 SWOT Analysis



List of Figures

FIG 1 Methodology for the research
FIG 2 LAMEA Oncology Drugs Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Oncology Drugs Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2019, Mar – 2023, Nov) Leading Players
FIG 7 Porter’s Five Forces Analysis - Oncology Drugs Market
FIG 8 LAMEA Oncology Drugs Market share by Indication, 2022
FIG 9 LAMEA Oncology Drugs Market share by Indication, 2030
FIG 10 LAMEA Oncology Drugs Market by Indication, 2019 - 2030, USD Million
FIG 11 LAMEA Oncology Drugs Market share by Drug Class Type, 2022
FIG 12 LAMEA Oncology Drugs Market share by Drug Class Type, 2030
FIG 13 LAMEA Oncology Drugs Market by Drug Class Type, 2019 - 2030, USD Million
FIG 14 LAMEA Oncology Drugs Market share by Country, 2022
FIG 15 LAMEA Oncology Drugs Market share by Country, 2030
FIG 16 LAMEA Oncology Drugs Market by Country, 2019 - 2030, USD Million
FIG 17 Recent strategies and developments: AbbVie, Inc.
FIG 18 Swot Analysis: AbbVie, Inc.
FIG 19 Swot Analysis: Amgen, Inc.
FIG 20 Recent strategies and developments: Astellas Pharma, Inc.
FIG 21 SWOT Analysis: Astellas Pharma, Inc.
FIG 22 Recent strategies and developments: AstraZeneca PLC
FIG 23 SWOT Analysis: AstraZeneca PLC
FIG 24 Recent strategies and developments: Bristol Myers Squibb Company
FIG 25 SWOT Analysis: Bristol Myers Squibb Company
FIG 26 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 27 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 28 Recent strategies and developments: Johnson & Johnson
FIG 29 Swot Analysis: Johnson & Johnson
FIG 30 SWOT Analysis: Novartis AG
FIG 31 Recent strategies and developments: Merck & Co., Inc.
FIG 32 SWOT Analysis: Merck & Co., Inc.
FIG 33 SWOT Analysis: Pfizer, Inc.

List of Tables

TABLE 1 LAMEA Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Oncology Drugs Market
TABLE 4 Product Launches And Product Expansions– Oncology Drugs Market
TABLE 5 Acquisition and Mergers– Oncology Drugs Market
TABLE 6 LAMEA Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 7 LAMEA Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 8 LAMEA Breast Cancer Market by Country, 2019 - 2022, USD Million
TABLE 9 LAMEA Breast Cancer Market by Country, 2023 - 2030, USD Million
TABLE 10 LAMEA Prostate Cancer Market by Country, 2019 - 2022, USD Million
TABLE 11 LAMEA Prostate Cancer Market by Country, 2023 - 2030, USD Million
TABLE 12 LAMEA Lung Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 13 LAMEA Lung Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 14 LAMEA Stomach Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 15 LAMEA Stomach Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 16 LAMEA Colorectal Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 17 LAMEA Colorectal Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 18 LAMEA Liver Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 19 LAMEA Liver Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 20 LAMEA Esophagus Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 21 LAMEA Esophagus Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 22 LAMEA Cervical Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 23 LAMEA Cervical Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 24 LAMEA Kidney Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 25 LAMEA Kidney Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 26 LAMEA Bladder Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 27 LAMEA Bladder Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 28 LAMEA Other Cancer Market by Country, 2019 - 2022, USD Million
TABLE 29 LAMEA Other Cancer Market by Country, 2023 - 2030, USD Million
TABLE 30 LAMEA Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 31 LAMEA Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 32 LAMEA Targeted Therapy Market by Country, 2019 - 2022, USD Million
TABLE 33 LAMEA Targeted Therapy Market by Country, 2023 - 2030, USD Million
TABLE 34 LAMEA Immunotherapy (Biologic Therapy) Market by Country, 2019 - 2022, USD Million
TABLE 35 LAMEA Immunotherapy (Biologic Therapy) Market by Country, 2023 - 2030, USD Million
TABLE 36 LAMEA Chemotherapy Market by Country, 2019 - 2022, USD Million
TABLE 37 LAMEA Chemotherapy Market by Country, 2023 - 2030, USD Million
TABLE 38 LAMEA Hormonal Therapy Market by Country, 2019 - 2022, USD Million
TABLE 39 LAMEA Hormonal Therapy Market by Country, 2023 - 2030, USD Million
TABLE 40 LAMEA Oncology Drugs Market by Country, 2019 - 2022, USD Million
TABLE 41 LAMEA Oncology Drugs Market by Country, 2023 - 2030, USD Million
TABLE 42 Brazil Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 43 Brazil Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 44 Brazil Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 45 Brazil Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 46 Brazil Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 47 Brazil Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 48 Argentina Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 49 Argentina Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 50 Argentina Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 51 Argentina Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 52 Argentina Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 53 Argentina Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 54 UAE Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 55 UAE Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 56 UAE Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 57 UAE Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 58 UAE Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 59 UAE Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 60 Saudi Arabia Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 61 Saudi Arabia Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 62 Saudi Arabia Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 63 Saudi Arabia Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 64 Saudi Arabia Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 65 Saudi Arabia Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 66 South Africa Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 67 South Africa Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 68 South Africa Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 69 South Africa Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 70 South Africa Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 71 South Africa Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 72 Nigeria Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 73 Nigeria Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 74 Nigeria Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 75 Nigeria Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 76 Nigeria Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 77 Nigeria Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 78 Rest of LAMEA Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 79 Rest of LAMEA Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 80 Rest of LAMEA Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 81 Rest of LAMEA Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 82 Rest of LAMEA Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 83 Rest of LAMEA Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 84 Key information – AbbVie, Inc.
TABLE 85 Key Information – Amgen, Inc.
TABLE 86 key information – Astellas Pharma, Inc.
TABLE 87 KEY INFORMATION – AstraZeneca PLC
TABLE 88 Key Information – Bristol Myers Squibb Company
TABLE 89 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 90 Key Information – Johnson & Johnson
TABLE 91 Key Information – Novartis AG
TABLE 92 Key Information - Merck & Co., Inc.
TABLE 93 Key Information – Pfizer, Inc.